Canada markets open in 9 hours 16 minutes

MERVAL (^MERV)

Buenos Aires - Buenos Aires Delayed Price. Currency in USD
Add to watchlist
38,390.84+233.89 (+0.61%)
At close: 5:02PM ART
Full screen
Previous Close38,156.95
Open38,156.95
Volume0
Day's Range38,156.95 - 39,015.46
52 Week Range21,738.62 - 56,114.04
Avg. Volume0
  • Reuters

    EMERGING MARKETS-Real up as Brazil, U.S. reinforce trade ties; China data lifts mood

    * Brazilian real breaks four-day losing streak * Brazil GDP to shrink 4% this year -officials * China's economic recovery quickens as consumption returns * Bolivia's socialists seal comeback win after tumultuous year (Updates prices throughout, adds bullets) By Shreyashi Sanyal Oct 19 (Reuters) - The Brazilian real firmed on Monday after the United States and Brazil agreed on steps to facilitate trade and investment in Latin America's biggest economy, while other currencies in the region were lifted by encouraging data from China. The real gained 0.6%, to rise for the first in five days after Brazilian President Jair Bolsonaro announced, at a virtual summit organized by the U.S. Chamber of Commerce, the three agreements to ensure good business practices and to stop corruption.

  • EMERGING MARKETS-Latam FX up on vaccine optimism, Chile's peso breaks 4-day losing streak
    Reuters

    EMERGING MARKETS-Latam FX up on vaccine optimism, Chile's peso breaks 4-day losing streak

    * Chilean peso up after central bank leaves rates unchanged * Argentina central bank lowers Leliq rate to 36% * Mexican peso outperforms Latam peers for the week (Updates prices throughout) By Shreyashi Sanyal Oct 16 (Reuters) - Latin American currencies rose on Friday after Pfizer Inc said it could apply for U.S. authorization of its COVID-19 vaccine as early as late November, while Chile's peso rose as its central bank held interest rates steady in its latest policy meeting. News of Pfizer Inc's vaccine, which the drugmaker is developing with German partner BioNTech, comes after global markets were jolted by the halting of two high-profiled COVID-19 vaccine trials earlier in the week.

  • Reuters

    EMERGING MARKETS-Latam FX rises on vaccine hopes, Chile's peso bucks 4-day losing streak

    * Chilean peso up after central bank leaves rates unchanged * Argentina central bank lowers Leliq rate to 36% * Mexican peso outperforms Latam peers for the week By Shreyashi Sanyal Oct 16 (Reuters) - Latin American currencies rose on Friday after Pfizer said it could apply for a U.S. emergency use of its COVID-19 vaccine in November, while Chile's peso rose as its central bank held interest rates steady in its latest policy meeting. News of Pfizer Inc's vaccine, which the drugmaker is developing with German partner BioNTech, comes after global markets were jolted by the halting of two high-profiled COVID-19 vaccine trials earlier in the week.